News
Hosted on MSN8mon
Hims & Hers drops 22% on Amazon competition concerns (update)Shares of telehealth services provider Hims & Hers (NYSE:HIMS) fell 22% Thursday after Amazon (NASDAQ:AMZN) announced it was entering the hair loss and erectile dysfunction treatment markets ...
Hims & Hers Health on Monday announced Nader Kabbani, a former Amazon executive who helped establish many of its health-care offerings, will join the telehealth company as its chief operations ...
Shares of Hims & Hers (HIMS) are sliding on Thursday after Amazon (AMZN) announced the launch of its Amazon One Medical Pay-per-visit telehealth service, which Citi believes is "very similar" to ...
Analysts at Bank of America downgraded shares of Hims & Hers from buy to underperform on Thursday, citing Amazon's push into hair loss and erectile dysfunction markets. The analysts said Hims ...
Analysts at Bank of America downgraded shares of Hims & Hers from buy to underperform on Thursday, citing Amazon's push into hair loss and erectile dysfunction markets. The analysts said Hims ...
BofA downgraded Hims & Hers (HIMS) to Underperform from Buy with a price target of $18, down from $32. Amazon (AMZN) launched a cash-pay telehealth service and treatment offering that could ...
Hims & Hers (HIMS) fell 22% after Amazon (AMZN) announced it was entering the hair loss and erectile dysfunction treatment markets through its telehealth unit. Read more here.
The analysts said Hims & Hers generates more than 80% gross margins from its core erectile dysfunction and hair loss offerings, and estimate that Amazon's medications for those conditions are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results